Loading...
XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia
β-thalassemia major (β-TM) is an inherited hemoglobinopathy caused by a quantitative defect in the synthesis of β-globin chains of hemoglobin, leading to the accumulation of free a-globin chains that aggregate and cause ineffective erythropoiesis. We have previously demonstrated that terminal erythr...
Na minha lista:
| Udgivet i: | Haematologica |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Fondazione Ferrata Storti
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7556489/ https://ncbi.nlm.nih.gov/pubmed/33054049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.210054 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|